Clinical Features of Peripheral Neurophaty among Onset Type 2 Diabestes Mellitus: A Michigan Neuropathy Screening Instrument (MNSI) Approach

Authors

  • Rian Adi Pamungkas Department of Nursing, Faculty of Health Sciences, Universitas Esa Unggul, Jakarta, Indonesia.
  • Andi Mayasari Usman Department of Nursing, Faculty of Health Science, Universitas Nasional, Jakarta, Indonesia.
  • Kanittha Chamroonsawasdi Department of Family Health, Faculty of Public Health, Mahidol University, Thailand.

Keywords:

Type 2 diabetes mellitus, Peripheral neuropathy, Clinical features, Michigan Neuropathy Screening Instrument

Abstract

Aims: Neuropathy is one of the complications that can occur in patients with Type 2 Diabetes Mellitus, around 21.3% to 34.5%. Untreated neuropathy can lead to diabetic foot ulcers that can lead to amputation. This can be prevented by conducting early detection using a neuropathy screening instrument. The study aimed to identify neuropathy symptoms through early examination of patients with type 2 diabetes using the Michigan Neuropathy Screening Instrument (MNSI).

Method: The descriptive study with a survey was approached in this study.  One hundred respondents with type 2 diabetes mellitus were selected using the purposive sampling technique.  

Results: The results showed that out of 100 patients had clinical symptoms of sensory neuropathy, such as pain and sensitivity disorders in the soles of the feet.  In addition, autonomic neuropathy is in the form of cramps in the leg muscles.  The level of neuropathy showed that from 100 patients, there were 59 respondents with low risk of neuropathy, 40 respondents with moderate risk, and 1 respondent with severe risk.  

Conclusion: Patients with Diabetes, primarily Type 2, have various neuropathy symptoms such as impaired nerve function: numbness, burning, and hypersensitivity, which can lead to diabetic foot ulcers.  Therefore, early detection of neuropathy prevention is essential.

References

Akaza, M., Akaza, I., Kanouchi, T., Sasano, T., Sumi, Y., & Yokota, T. (2018). Nerve Conduction Study of The Association Between Glycemic Variability and Diabetes Neuropathy. Diabetology and Metabolic Syndrome, 10(1), 1–8. https://doi.org/10.1186/s13098-018-0371-0

Albers, J. W., & Pop-Busui, R. (2014). Diabetic Neuropathy: Mechanisms, Emerging Treatments, and Subtypes. Curr Neurol Neurosci Rep, 14(8), 473. https://doi.org/10.1007/s11910-014-0473-5

Andersen, S. T., Witte, D. R., Dalsgaard, E. M, Andersen, H., Nawroth, P., Fleming, T., Jensen, T. M., Finnerup, N. B., Jensen, T. S., Lauritzen, T., Feldman, E. L., Callaghan, B. C., & Charles, M. (2018). Risk Factors for Incident Diabetic Polyneuropathy in a Cohort with Screen-Detected Type 2 Diabetes Followed for 13 Years: ADDITION-Denmark. Diabetes Care. 41(5), 1068-1075. https://doi.org/10.2337/dc17-2062

Bondor, C. I., Veresiu, I. A., Florea, B., Vinik, E. J., Vinik, A. I., & Gavan, N. A. (2016). Epidemiology of Diabetic Foot Ulcers and Amputations in Romania: Results of a Cross-Sectional Quality of Life Questionnaire Based Survey. Journal of Diabetes Research. 2016:e5439521. https://doi.org/10.1155/2016/5439521

Carmichael, J., Fadavi, H., Ishibashi, F., Shore, A. C., & Tavakoli, M. (2021). Advances in Screening, Early Diagnosis and Accurate Staging of Diabetic Neuropathy. Frontiers in endocrinology, 12, 671257. https://doi.org/10.3389/fendo.2021.671257

Freeman, R., Baron, R., Bouhassira, D., Cabrera, J., & Emir, B. (2014). Sensory Profiles of Patients with Neuropathic Pain Based on the Neuropathic Pain Symptoms and Signs. Pain, 155(2), 367–376. https://doi.org/10.1016/j.pain.2013.10.023

Halawa, M. R., Karawagh, A., Zeida, A., Mahmoud, A. E., Sakr, M., & Hegazy, A. (2010). Prevalence of Painful Diabetic Peripheral Neuropathy Among Patients Suffering from Diabetes Mellitus in Saudi Arabia. Current medical research and opinion, 26(2), 337–343. https://doi.org/10.1185/03007990903471940

Hwang, S., van Nooten, F., Wells, T., Ryan, A., Crawford, B., Evans, C., & English, M. (2018). Neuropathic pain: A Patient-centered Approach to Measuring Outcomes. Health Expectations, 21(4), 774–786. https://doi.org/10.1111/hex.12673

Kim, S. S., Won, J. C., Kwon, H. S., Kim, C. H., Lee, J. H., Park, T. S., Ko, K. S., & Cha, B. Y. (2014). Prevalence and clinical implications of painful diabetic peripheral neuropathy in type 2 diabetes: results from a nationwide hospital-based study of diabetic neuropathy in Korea. Diabetes research and clinical practice, 103(3), 522–529. https://doi.org/10.1016/j.diabres.2013.12.003

Adi Pamungkas, R., Mayasari Usman, A., Chamroonsawasdi, K., Khoirunisa, D., Nur Hamzah, A., & Hidayat, R. (2022). Challenges of Neuropathy Screening for Preventing Diabetic Foot Ulcers: Perspectives of Public Health Nurses in Indonesia. KnE Life Sciences, 7(2), 46–58. https://doi.org/10.18502/kls.v7i2.10287

Ponirakis, G., Elhadd, T., Chinnaiyan, S., Dabbous, Z., Siddiqui, M., Al-Muhannadi, H., Petropoulos, I., Khan, A., Ashawesh, K. A., Dukhan, K. M., Mahfoud, Z. R., Murgatroyd, C., Slevin, M., & Malik, R. A. (2019). Prevalence and risk factors for painful diabetic neuropathy in secondary healthcare in Qatar. Journal of diabetes investigation, 10(6), 1558–1564. https://doi.org/10.1111/jdi.13037

Qureshi, M. S., Iqbal, M., Zahoor, S., Ali, J., & Javed, M. U. (2017). Ambulatory screening of diabetic neuropathy and predictors of its severity in outpatient settings. Journal of endocrinological investigation, 40(4), 425–430. https://doi.org/10.1007/s40618-016-0581-y

Raskin, J., Pritchett, Y. L., Wang, F., D'Souza, D. N., Waninger, A. L., Iyengar, S., & Wernicke, J. F. (2005). A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain. Pain medicine (Malden, Mass.), 6(5), 346–356. https://doi.org/10.1111/j.1526-4637.2005.00061.x

Pop-Busui, R., Boulton, A. J., Feldman, E. L., Bril, V., Freeman, R., Malik, R. A., Sosenko, J. M., & Ziegler, D. (2017). Diabetic Neuropathy: A Position Statement by the American Diabetes Association. Diabetes care, 40(1), 136–154. https://doi.org/10.2337/dc16-2042

Timar, B., Timar, R., Gaiță, L., Oancea, C., Levai, C., & Lungeanu, D. (2016). The Impact of Diabetic Neuropathy on Balance and on the Risk of Falls in Patients with Type 2 Diabetes Mellitus: A Cross-Sectional Study. PloS one, 11(4), e0154654. https://doi.org/10.1371/journal.pone.0154654

Tesfaye, S., Chaturvedi, N., Eaton, S. E., Ward, J. D., Manes, C., Ionescu-Tirgoviste, C., Witte, D. R., Fuller, J. H., & EURODIAB Prospective Complications Study Group (2005). Vascular risk factors and diabetic neuropathy. The New England journal of medicine, 352(4), 341–350. https://doi.org/10.1056/NEJMoa032782

Tavakoli, M., Gogas Yavuz, D., Tahrani, A. A., Selvarajah, D., Bowling, F. L., & Fadavi, H. (2017). Diabetic Neuropathy: Current Status and Future Prospects. Journal of diabetes research, 2017, 5825971. https://doi.org/10.1155/2017/5825971

Walter-Höliner, I., Barbarini, D. S., Lütschg, J., Blassnig-Ezeh, A., Zanier, U., Saely, C. H., & Simma, B. (2018). High Prevalence and Incidence of Diabetic Peripheral Neuropathy in Children and Adolescents With Type 1 Diabetes Mellitus: Results From a Five-Year Prospective Cohort Study. Pediatric neurology, 80, 51–60. https://doi.org/10.1016/j.pediatrneurol.2017.11.017

Zychowska, M., Rojewska, E., Przewlocka, B., & Mika, J. (2013). Mechanisms and Pharmacology of Diabetic Neuropathy-experimental and Clinical Studies. Pharmacological reports: PR, 65(6), 1601–1610. https://doi.org/10.1016/s1734-1140(13)71521-4

Downloads

Published

2023-02-28